AMSSM: Autologous stem cells show promise for ACL tears

AMSSM: autologous stem cells show promise for ACL tears
For patients with partial or complete non-retracted anterior cruciate ligament (ACL) tears, injection of autologous mesenchymal stem cells directly into the ACL sheath may help heal the tear, according to a study presented at the annual meeting of the American Medical Society of Sports Medicine, held from April 17 to 21 in San Diego.

(HealthDay)—For patients with partial or complete non-retracted anterior cruciate ligament (ACL) tears, injection of autologous mesenchymal stem cells directly into the ACL sheath may help heal the tear, according to a study presented at the annual meeting of the American Medical Society of Sports Medicine, held from April 17 to 21 in San Diego.

Benjamin Newton, M.D., from the Centeno-Schultz Clinic in Broomfield, Colo., and colleagues treated seven patients with partial or complete non-retracted tear ACLs, confirmed by (MRI), to assess the impact of autologous injected directly into the ACL sheath.

The researchers identified radiographic and subjective improvement in five of the seven patients. Three of the five had returned to their pre-injury level of activity. One patient did not respond to therapy and one did not undergo post-procedure imaging.

"Using autologous mesenchymal stem cells injected directly into the ACL sheath results in healing which is appreciated on MRI and improvement of function by patient," the authors write. "The regenerative properties of mesenchymal stem cells in the world of orthopedics [show] promise."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

The impact of bacteria in our guts

19 hours ago

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

20 hours ago

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

21 hours ago

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments